Hartford多因子小型股ETF ROSC 深 沪
已收盘 02-06 16:00:00 美东时间
51.1988
+1.118
+2.23%
华盛通- 最 高51.1988
- 今 开50.60
- 成交量 1186股
- 最 低 50.60
- 昨 收 50.0804
- 总市值 3839.91万
- 52周最高 51.1988
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 34.7185
- 委 比 0.00%
- 总股本 75.00万
- 历史最高 51.1988
- 量 比 0.02
- 振 幅 1.20%
- 历史最低 12.9823
- 每 手 1
- 风险率 3.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Firefly Neuroscience Inc May Offer, Sell Shares Of Common Stock Of Up To $7.4 Million From Time To Time
BRIEF-Firefly Neuroscience Inc May Offer, Sell Shares Of Common Stock Of Up To $7.4 Million From Time To Time Firefly Neuroscience Inc AIFF.O : FIREFLY NEUROSCIENCE INC: MAY OFFER, SELL SHARES OF COMMON STOCK OF UP TO $7.4 MILLION FROM TIME TO TIME Source text: [ID:n0001213900-26-011524] Further com
02-04 07:29
BRIEF-Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users
BRIEF-Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users Jan 28 (Reuters) - Jupiter Neurosciences Inc JUNS.O : JUPITER NEUROSCIENCES INC - ANNOUNCES STRATEGIC INITIATIVE FOR GLP-1 USERS Source text: ID:nGNX8RPntl Further company coverage: JUNS.O (( Reuters.Briefs@thom
01-28 19:02
BRIEF-Vigil Neuroscience Reports Positive Data From Its Phase 1 Clinical Trial
Jan 23 (Reuters) - Vigil Neuroscience Inc VIGL.O: VIGIL NEUROSCIENCE REPORTS POSITIVE DATA FROM ITS PHASE 1 CLINICAL TRIAL EVALUATING VG-3927 FOR THE POTENTIAL TREATMENT OF ALZHEIMER’S DISEASE VIGIL N...
2025-01-23 20:12
BRIEF-Alto Neuroscience Amends Loan And Security Agreement
Jan 16 (Reuters) - Alto Neuroscience Inc ANRO.N: ALTO NEUROSCIENCE INC - AMENDS LOAN AND SECURITY AGREEMENT ALTO NEUROSCIENCE INC - MATURITY DATE EXTENDED TO JANUARY 1, 2029 ALTO NEUROSCIENCE INC - MA...
2025-01-16 20:59
BRIEF-Johnson & Johnson To Acquire Intra-Cellular Therapies for $14.6 billion
Jan 13 (Reuters) - Johnson & Johnson JNJ.N: JOHNSON & JOHNSON STRENGTHENS NEUROSCIENCE LEADERSHIP WITH ACQUISITION OF INTRA-CELLULAR THERAPIES, INC. JOHNSON & JOHNSON - DEAL VALUED AT $14.6 BILLION, $...
2025-01-13 19:50
BRIEF-Firefly Neuroscience Appoints Greg Lipschitz As Interim CEO
Jan 6 (Reuters) - Firefly Neuroscience Inc AIFF.O: FIREFLY NEUROSCIENCE INC: BOARD REMOVED JON OLSEN FROM HIS POSITION AS CO'S CEO FIREFLY NEUROSCIENCE INC: APPOINTED GREG LIPSCHITZ AS CO'S INTERIM CE...
2025-01-07 05:45
